Details for New Drug Application (NDA): 020180

✉ Email this page to a colleague

NDA 020180 describes PROSCAR, which is a drug marketed by Organon and is included in one NDA. It is available from one supplier. Additional details are available on the PROSCAR profile page.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the finasteride profile page.

Summary for 020180

Tradename:	PROSCAR
Applicant:	Organon
Ingredient:	finasteride
Patents:	0

Pharmacology for NDA: 020180

Mechanism of Action	5-alpha Reductase Inhibitors

Medical Subject Heading (MeSH) Categories for 020180

5-alpha Reductase Inhibitors
Urological Agents

Suppliers and Packaging for NDA: 020180

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PROSCAR	finasteride	TABLET;ORAL	020180	NDA	Organon LLC	78206-153	78206-153-01	30 TABLET, FILM COATED in 1 BOTTLE (78206-153-01)
PROSCAR	finasteride	TABLET;ORAL	020180	NDA	Organon LLC	78206-153	78206-153-02	100 TABLET, FILM COATED in 1 BOTTLE (78206-153-02)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Jun 19, 1992	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020180

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	4,377,584	⤷ Get Started Free
Organon	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	5,942,519	⤷ Get Started Free
Organon	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	6,046,183	⤷ Get Started Free
Organon	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	5,886,184	⤷ Get Started Free
Organon	PROSCAR	finasteride	TABLET;ORAL	020180-001	Jun 19, 1992	4,760,071	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.